You are here: Industry Insights > Insilico Medicine

News List

Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus prnasia
June 23, 2021
Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million Series C financing led by Warburg Pincus.
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen prnasia
November 10, 2020
Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, announced that it entered into a multi-target drug discovery agreement with Janssen ...
Insilico partners with Taisho on end-to-end AI-powered senolytic drug discovery prnasia
October 16, 2020
Insilico Medicine announced today that Taisho Pharmaceutical Co., Ltd. and Insilico have entered into a research collaboration to identify novel therapeutics against aging.
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million En-CPhI.CN
October 11, 2019
Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning ...
CTFH, Insilico Medicine enter Al drug discovery collaboration biospectrumasia
October 10, 2019
CTFH is an active adopter of state-of-the-art technologies and has achieved significant milestones in first-in-class drug development.
Insilico Medicine secures $37M in series B funding biospectrumasia
September 10, 2019
The Series B funding will be used to commercialize the validated generative chemistry and target identification technology.
Insilico Medicine uses AI to transform drug discovery biospectrumasia
September 03, 2019
Invention and scientific validation of GENTRL, an AI-powered system capable of creating new molecules in 21 days.
Insilico Medicine Starts Asia's First AI R&D Base in Taiwan, China biospectrumasia
March 26, 2018
The companies will form an alliance with the Center for Biotechnology, the Institute for Information Industry, and TUL Corporation to implement the "AI Digital Health Talent Development Project
Leading US Artificial Intelligence Company Insilico Medicine Establishes Asia's First AI R&D Base in Taiwan, China prnasia
March 23, 2018
Developing Taiwan, China's AI Talent together with the Development Center for Biotechnology, Institute for Information Industry, and TUL Corporation